CPRX Historical Earnings image   This CPRX historical earnings page last updated 11/11/2022
CPRX Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/9/20220.06B
Q2 20228/9/20220.05B
Q1 20225/10/20220.04B
Q4 20213/16/20220.04B
Q3 202111/9/20210.04B
Q2 20218/9/20210.04B
Q1 20215/10/20210.03B
Q4 20203/15/20210.03B
Q3 202011/9/20200.03B
Q2 20208/10/20200.03B
Q1 20205/11/20200.03B
Q4 20193/16/20200.03B
Q3 201911/12/20190.03B
Q2 20198/7/20190.03B
Q1 20195/13/20190.01B
Q4 20183/18/2019500000
Q3 201811/7/2018NA
Q2 20188/7/2018NA
Q1 20185/9/2018NA
Q4 20173/14/2018NA
Q3 201711/8/2017NA
Q2 20178/9/2017NA
Q1 20175/10/2017NA
Q4 20163/15/2017NA
Q3 201611/9/2016NA
Q2 20168/9/2016NA
Q1 20165/10/2016NA
Q4 20153/15/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/11/2015NA
Q4 20143/16/2015NA
Q3 201411/14/2014NA
Q2 20148/14/2014NA
Q1 20145/16/2014NA
Q4 20133/19/2014NA
Q3 201311/13/2013NA
Q2 20138/15/2013NA
Q1 20135/16/2013NA
Q4 20124/2/2013NA
Q3 201211/15/2012NA
Q2 20128/15/2012NA
CPRX Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q3 202211/9/20220.260
Q2 20228/9/20220.280
Q1 20225/10/20220.120
Q4 20213/16/20220.090
Q3 202111/9/20210.100
Q2 20218/9/20210.110
Q1 20215/10/20210.070
Q4 20203/15/20210.110
Q3 202011/9/20200.130
Q2 20208/10/20200.090
Q1 20205/11/20200.100
Q4 20193/16/20200.070
Q3 201911/12/20190.130
Q2 20198/7/20190.100
Q1 20195/13/2019-0.010
Q4 20183/18/2019-0.14
Q3 201811/7/2018-0.08
Q2 20188/7/2018-0.06
Q1 20185/9/2018-0.06
Q4 20173/14/2018-0.06
Q3 201711/8/2017-0.05
Q2 20178/9/2017-0.05
Q1 20175/10/2017-0.06
Q4 20163/15/2017-0.05
Q3 201611/9/2016-0.05
Q2 20168/9/2016-0.06
Q1 20165/10/2016-0.07
Q4 20153/15/2016-0.07
Q3 201511/9/2015-0.06
Q2 20158/10/2015-0.06
Q1 20155/11/2015-0.06
Q4 20143/16/2015-0.05
Q3 201411/14/2014-0.06
Q2 20148/14/2014-0.05
Q1 20145/16/2014-0.07
Q4 20133/19/2014-0.05
Q3 201311/13/2013-0.13
Q2 20138/15/2013-0.06
Q1 20135/16/2013-0.04
Q4 20124/2/2013-0.140
Q3 201211/15/2012-0.08
Q2 20128/15/2012-0.01
Quotes delayed 20 minutes

Email EnvelopeFree CPRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Catalyst Pharmaceuticals (CPRX) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CRBP Historical Earnings
CRBU Historical Earnings
CRDF Historical Earnings
CRIS Historical Earnings
CRL Historical Earnings
CRMD Historical Earnings
CRNX Historical Earnings
CRTX Historical Earnings
CRVL Historical Earnings
CRVS Historical Earnings
What was the record high CPRX historical earnings result?
In terms of earnings or revenue, what is the best CPRX historical earnings result that Catalyst Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CPRX historical earnings result was set in Q2 2022, when Catalyst Pharmaceuticals posted results of 0.280/share. The most successful revenue quarter within our data set was Q3 2022 when Catalyst Pharmaceuticals reported revenue of 0.06B.

What was the lowest Catalyst Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CPRX has reported, and when?

✔️Accepted answer: Within our data set, the lowest CPRX historical earnings result was set in Q4 2018, when Catalyst Pharmaceuticals posted results of -0.14/share. The smallest revenue quarter within our data set was Q3 2018 when Catalyst Pharmaceuticals reported revenue of NA.

On this page we presented the CPRX historical earnings date information for Catalyst Pharmaceuticals. Reviewing that CPRX Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q2 2022, when CPRX posted adjusted EPS of 0.280/share. Meanwhile the lowest CPRX historical earnings result was in Q4 2018, when CPRX posted adjusted EPS of -0.14/share. Moving to Catalyst Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2022 when CPRX reported 0.06B in revenue, while the smallest revenue quarter was Q3 2018 when CPRX reported NA in revenue.

For self directed investors doing their due diligence on CPRX or any other given stock, their research can benefit from looking into all of the Catalyst Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Catalyst Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CPRX. Thanks for visiting, and the next time you need to research CPRX historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: CBCR Insider Buying, IFV Average Annual Return, Funds Holding NERV.

 

CPRX Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.